India’s drug business shot up in the month of October 2020 due to increased sales and marketing activities by pharmaceutical companies, with unlocking. The Indian pharmaceutical market (IPM) grew 9.6 per cent on-year in the month, led by volume and price growth and an increase in products launches, said a report by India Ratings. While the prices grew 5 per cent, products were launched at a 3.7 per cent higher rate. The pharma market reported total sales of Rs 13,540 crore for October 2020. Revenue majorly grew in acute therapies, and chronic and sub-chronic therapies.
The revenue in acute therapies grew 6 per cent on-year while that in chronic and sub-chronic therapies rose 13 per cent on-year each in the month. Acute therapies such as vitamins, gastro witnessed significant revenue growth of 22.6 per cent and 13.6 per cent on-year, respectively.
Source: Financial Express
